Daura Gold starts Phase II drilling at La Flora gold-silver project in Argentina
Bitget2026/10/08 11:31Daura Gold began Phase II diamond drilling across the Cerro Bayo–La Flora projects in Santa Cruz, Argentina. Program targets about 1,600 meters in 20 holes across four zones, starting with 900 meters in 12 holes at La Flora. La Flora drilling marks the first subsurface test of high-grade veins, following surface samples up to 82.19 g/t gold and 1,239.28 g/t silver. Work then shifts to Cerro Bayo for follow-up at Elena, where Phase I hit 11.95 meters at 2.00 g/t gold. Step-outs planned at Ingrid, where Phase I returned 16.35 meters at 89.0 g/t silver, plus initial drilling at the Gabriela target. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Daura Gold Corp. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610080730NEWSFILECNPR____20261008_318042_1) on October 08, 2026, and is solely responsible for the information contained therein.
- Daura Gold began Phase II diamond drilling across the Cerro Bayo–La Flora projects in Santa Cruz, Argentina.
- Program targets about 1,600 meters in 20 holes across four zones, starting with 900 meters in 12 holes at La Flora.
- La Flora drilling marks the first subsurface test of high-grade veins, following surface samples up to 82.19 g/t gold and 1,239.28 g/t silver.
- Work then shifts to Cerro Bayo for follow-up at Elena, where Phase I hit 11.95 meters at 2.00 g/t gold.
- Step-outs planned at Ingrid, where Phase I returned 16.35 meters at 89.0 g/t silver, plus initial drilling at the Gabriela target.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
Crypto prices
More
